Cardinal Health’s Strong Future Prospects and Upward Guidance Drive Buy Rating
Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...
Cardinal Health’s CIO On Innovation, Talent And Empathy In Leadership
Michelle Greene leads with emphathy. She believes that has been her secret sauce in forging productive bonds across her ...
Cardinal Health’s Strong Pharmaceutical Performance and Strategic Growth Drive Buy Rating
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...